Palliative Short Course Radiotherapy for Advanced Thoracic Cancer

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status: Completed

Conditions: Palliative Care

Treatments: Radiation: Short course radiotherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03465553

SHARON LUNG

Details and patient eligibility

About

The study wants to define the maximum tolerated dose (MTD), safety and efficacy of a short course radiation therapy in patients with symptomatic advanced thoracic cancer.

Full description

The study wants to define the maximum tolerated dose (MTD) of a conformal short course accelerated radiation therapy delivered in twice daily fractions and 2 consecutive days, and the feasibility of this fractionation in term of safety and efficacy for symptomatic palliation of advanced thoracic cancer.

Enrollment: 53 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• histologically proven advanced thoracic cancer
• excluded from curative therapy because of disease stage and/or presence of multiple comorbidities and/or poor performance status
• age > 18 years
• Eastern Cooperative Oncology Group (ECOG) <3

Exclusion criteria

• prior radiotherapy to the same region

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

53 participants in 1 patient group

Short course radiotherapy

Experimental group

Description:

The radiotherapy is delivered over 2 days with accelerated hypo-fractionation.

Treatment:

Radiation: Short course radiotherapy